Skip to content

A predictive model for the progression of nonfunctional pituitary microadenomas

A predictive model for the progression of nonfunctional pituitary microadenomas

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035751
Enrollment
Unknown
Registered
2020-08-16
Start date
2020-08-10
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonfunctional pituitary microadenomas

Interventions

Gold Standard:Clinical outcomes
Index test:A&#32
predictive&#32
model&#32
for&#32
the&#32
of&#32
nonfunctional&#32
microadenomas.

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with pituitary adenoma confirmed by MRI and without hormone secretion function by laboratory test; 2. Patients with tumor diameter <= 1cm; 3. The patients who voluntarily join the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with obvious compression symptoms caused by tumor, such as headache, vision and visual field disturbance; 2. The patients with stroke in tumor; 3. Patients with a history of gamma knife radiosurgery; 4. Patients with malignant tumor of other organs or other systemic diseases with life expectancy less than 1 year; 5. Patients with poor general condition and unsuitable for follow-up observation.

Design outcomes

Primary

MeasureTime frame
Demographic data;SEN, SPE, ACC, AUC of ROC;

Secondary

MeasureTime frame
Materials related to living habits;Data on past medical history;Materials related to family history;Data related to drug history;Laboratory related data;Imaging data;

Countries

China

Contacts

Public ContactJianguo Xu

West China Hospital of Sichuan University

jianguo_1229@126.com+86 18980602049

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026